• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES ENDOSCOPIC GORE SEAMGUARD BIOABSORBABLE STAPLE LINE REINFORCEMENT; MESH, SURGICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES ENDOSCOPIC GORE SEAMGUARD BIOABSORBABLE STAPLE LINE REINFORCEMENT; MESH, SURGICAL Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Stenosis (2263)
Event Date 10/01/2015
Event Type  Injury  
Manufacturer Narrative
Patient information was requested but no information was provided.The date of event, lot/serial number was also requested, but no information has been provided.As the event date is unknown, the event date reported is the date of the publication.
 
Event Description
The following publication which mentions gore® seamguard® bioabsorbable staple line reinforcement was reviewed: simple versus reinforced cruroplasty in patients submitted to concomitant laparoscopic sleeve gastrectomy: prospective evaluation in a bariatric center of excellence.Background: crural closure in addition to laparoscopic sleeve gastrectomy (lsg) represents a valuable option for the synchronous management of morbid obesity and hiatal defects, providing good outcomes in terms of weight loss and gastroesophageal reflux disease (gerd) symptoms control.The aim of this prospective study was to evaluate the safety and effectiveness of the reinforced cruroplasty during lsg compared with a concurrent group of simple cruroplasty.Methods: the study groups included 96 morbidly obese patients who underwent simultaneous lsg and cruroplasty.Group a: 48 patients with hiatal areal defect\4 cm2 and normal pillars (simple posterior cruroplasty); group b: 48 patients with hiatal areal defect[4 and\8 cm2 with weakness of the right pillar (on-lay synthetic absorbable mesh-reinforced cruroplasty).Upper gi symptoms were assessed by roma iii standard questionnaire.Endoscopy, imaging, esophageal 24-h ph monitoring and hrmanometry were performed in cases of persistent or recurrent symptoms after surgery.Results: once case of midgastric stenosis occurred that was treated by endoscopic dilation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDOSCOPIC GORE SEAMGUARD BIOABSORBABLE STAPLE LINE REINFORCEMENT
Type of Device
MESH, SURGICAL
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MPD APC B/P
p.o. box 1408
elkton MD 21922 1408
Manufacturer Contact
cheryl hawke
1500 n. 4th street
9285263030
MDR Report Key10244679
MDR Text Key197944238
Report Number3003910212-2020-00116
Device Sequence Number1
Product Code FTM
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
K043056
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Reporter Occupation Physician
Type of Report Initial
Report Date 06/12/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/08/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-